FDA inspection
Bayer AG: FDA inspection ending May 13, 2022
FDA inspection 1209999 · No Action Indicated (NAI) · Leverkusen
Key facts
| Inspection ID | 1209999 |
|---|---|
| Firm | Bayer AG |
| FEI number | 3002806462 |
| Address | Kaiser-Wilhelm-Allee 101-103 |
| City | Leverkusen |
| Country | Germany |
| Fiscal year | 2022 |
| Inspection end date | May 13, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data